192 related articles for article (PubMed ID: 7158983)
1. [Electrophysiologic study of propafenon in Wolff-Parkinson-White syndrome].
Clémenty J; Sourdille N; Pedeboscq G; Bricaud H
Ann Cardiol Angeiol (Paris); 1982; 31(5):351-5. PubMed ID: 7158983
[No Abstract] [Full Text] [Related]
2. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
3. [Progress in arrhythmology].
Furlanello F; Bettini R; Dal Forno P; Vergara G; Stefenelli C; Zuechi S; Inama G; Disertori M
G Ital Cardiol; 1981; 11 Suppl 1():202-53. PubMed ID: 7035271
[No Abstract] [Full Text] [Related]
4. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
5. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
Seipel L; Breithardt G; Both A
Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
[TBL] [Abstract][Full Text] [Related]
6. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
Beck OA; Hochrein H
Dtsch Med Wochenschr; 1978 Aug; 103(32):1261-5. PubMed ID: 78793
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic effects of intravenous dauricine on accessory pathway in Wolff-Parkinson-White syndrome].
Liu YW; Mao HY; Guo JH
Zhonghua Nei Ke Za Zhi; 1987 Sep; 26(9):541-5, 565-6. PubMed ID: 3450477
[No Abstract] [Full Text] [Related]
9. [Fatal poisoning with the antiarrhythmic agent propafenon].
Bösche J; Mattern R
Beitr Gerichtl Med; 1980; 38():231-4. PubMed ID: 7458822
[No Abstract] [Full Text] [Related]
10. [The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
Neumann G; Grube E; Funke H
Herz; 1983 Jun; 8(3):153-64. PubMed ID: 6873862
[No Abstract] [Full Text] [Related]
11. [Influence of propafenon on hemodynamics of the left ventricle and atrioventricular conduction with special reference to the WPW syndrome].
Probst P; Pachinger O
Z Kardiol; 1976 Mar; 65(3):213-24. PubMed ID: 1258514
[TBL] [Abstract][Full Text] [Related]
12. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
[No Abstract] [Full Text] [Related]
13. [Wolff-Parkinson-White syndrome with paroxysmal supraventricular tachycardias of the fetus and the newborn--case report].
Gembruch U; Venn HJ; Redel DA; Hansmann M
Klin Padiatr; 1982; 194(5):320-3. PubMed ID: 7144049
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiological evaluation of the anti-arrhythmia activity of ethmozin and its diethylamine analog in patients with Wolff-Parkinson-White syndrome].
Shugushev KhKh; Rozenshtraukh LV; Smetnev AS
Ter Arkh; 1982; 54(5):84-91. PubMed ID: 7048614
[No Abstract] [Full Text] [Related]
15. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
[No Abstract] [Full Text] [Related]
16. [Clinical picture and therapy of tachycardia including the WPW-syndrome].
Schlepper M
Verh Dtsch Ges Inn Med; 1975; 81():119-31. PubMed ID: 1229434
[No Abstract] [Full Text] [Related]
17. [Effect of verapamil on electrophysiologic characteristics of the accessory pathway in patients with Wolff-Parkinson-White syndrome].
Molenda W; Telichowski C; Góral J; Banasiak W; Metner E; Petruk J
Pol Tyg Lek; 1988 Sep; 43(36):1157-60. PubMed ID: 3251208
[No Abstract] [Full Text] [Related]
18. [Electrophysiologic characterization of propafenone in man].
Masini G; Dianda R; Masini M
G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
[TBL] [Abstract][Full Text] [Related]
19. The pseudoventricular tachycardias in the Wolff-Parkinson-White syndrome.
Johnson CD
Bol Asoc Med P R; 1979 Feb; 71(2):34-47. PubMed ID: 287470
[No Abstract] [Full Text] [Related]
20. Electrophysiologic effects, efficacy and tolerance of class Ic antiarrhythmic agents in Wolff-Parkinson-White syndrome.
Manolis AS; Salem DN; Estes NA
Am J Cardiol; 1989 Mar; 63(11):746-50. PubMed ID: 2493734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
